{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Regimen&page=41", "query": { "intervention": "Control Regimen", "page": 41 }, "page_size": 10 }, "pagination": { "page": 41, "page_size": 10, "total_count": 1567, "total_pages": 157, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Regimen&page=42&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Regimen&page=40&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-01T15:32:07.098Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04372589", "title": "Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "COVID-19", "Pneumonia" ], "interventions": [ { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Manitoba", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1200, "start_date": "2020-05-20", "completion_date": "2021-05-17", "has_results": false, "last_update_posted_date": "2021-07-27", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 13, "location_summary": "Atlanta, Georgia • Chicago, Illinois • Jefferson, Louisiana + 10 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Jefferson", "state": "Louisiana" }, { "city": "Portland", "state": "Maine" }, { "city": "Dearborn", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04372589" }, { "nct_id": "NCT03526861", "title": "Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Tralokinumab", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 301, "start_date": "2018-06-19", "completion_date": "2021-03-16", "has_results": true, "last_update_posted_date": "2025-03-11", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Fort Smith, Arkansas • Fountain Valley, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03526861" }, { "nct_id": "NCT02367833", "title": "Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bone; Disorder, Development and Growth" ], "interventions": [ { "name": "Combined Oral Contraceptive", "type": "DRUG" }, { "name": "Transdermal Contraceptive", "type": "DRUG" }, { "name": "Contraceptive Vaginal Ring", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Penn State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "FEMALE", "summary": "18 Years to 30 Years · Female only" }, "enrollment_count": 60, "start_date": "2015-01", "completion_date": "2018-12", "has_results": true, "last_update_posted_date": "2020-03-09", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 1, "location_summary": "University Park, Pennsylvania", "locations": [ { "city": "University Park", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02367833" }, { "nct_id": "NCT00587158", "title": "Oral Paricalcitol in Kidney Transplant Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Transplant; Failure, Kidney", "Renal Disease, End Stage", "Hyperparathyroidism, Secondary" ], "interventions": [ { "name": "Paricalcitol", "type": "DRUG" }, { "name": "Corticosteroid Avoidance Immune Suppression Protocol", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2007-01", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2013-05-13", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 2, "location_summary": "Scottsdale, Arizona • Rochester, Minnesota", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00587158" }, { "nct_id": "NCT03945747", "title": "MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type1 Diabetes Mellitus", "Diabetes Mellitus, Type 1", "Autoimmune Diabetes", "Juvenile Diabetes", "Diabetes Mellitus Complication", "Diabetic Nephropathies", "Metabolic Disease", "Diabetic Kidney Disease" ], "interventions": [ { "name": "Blood draw", "type": "DIAGNOSTIC_TEST" }, { "name": "Urine sample collection", "type": "DIAGNOSTIC_TEST" }, { "name": "DXA scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "7 Years to 18 Years" }, "enrollment_count": 50, "start_date": "2019-08-14", "completion_date": "2026-08-01", "has_results": false, "last_update_posted_date": "2025-03-30", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03945747" }, { "nct_id": "NCT07217665", "title": "The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "PSP - Progressive Supranuclear Palsy" ], "interventions": [ { "name": "AADvac1", "type": "BIOLOGICAL" }, { "name": "Matching Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Adam Boxer", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "41 Years", "maximum_age": "86 Years", "sex": "ALL", "summary": "41 Years to 86 Years" }, "enrollment_count": 146, "start_date": "2026-07-29", "completion_date": "2030-09-28", "has_results": false, "last_update_posted_date": "2026-08-13", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07217665" }, { "nct_id": "NCT03146416", "title": "Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Evinacumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 96, "start_date": "2017-05-16", "completion_date": "2018-06-14", "has_results": false, "last_update_posted_date": "2018-06-25", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03146416" }, { "nct_id": "NCT03310463", "title": "Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acinetobacter Baumannii Infection" ], "interventions": [ { "name": "ETX2514SUL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Entasis Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 34, "start_date": "2017-10-03", "completion_date": "2018-05-29", "has_results": false, "last_update_posted_date": "2018-06-14", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 3, "location_summary": "Lakewood, Colorado • Miami, Florida • Minneapolis, Minnesota", "locations": [ { "city": "Lakewood", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03310463" }, { "nct_id": "NCT07881887", "title": "A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity", "Overweight", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "LY4167586", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 617, "start_date": "2026-10", "completion_date": "2029-03", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 11, "location_summary": "Anaheim, California • Los Alamitos, California • Walnut Creek, California + 8 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07881887" }, { "nct_id": "NCT04816721", "title": "A Study to Evaluate EDP 938 Regimens in Children With RSV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Syncytial Virus (RSV)" ], "interventions": [ { "name": "EDP-938", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Enanta Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "28 Days", "maximum_age": "36 Months", "sex": "ALL", "summary": "28 Days to 36 Months" }, "enrollment_count": 99, "start_date": "2022-04-26", "completion_date": "2024-08-19", "has_results": true, "last_update_posted_date": "2025-07-28", "last_synced_at": "2026-11-01T15:32:07.098Z", "location_count": 16, "location_summary": "Long Beach, California • Los Angeles, California • Sacramento, California + 12 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04816721" } ] }